Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Infections after lung transplantation.

Robin K Avery1

  • 1Department of Infectious Disease, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA. averyr@ccf.org

Seminars in Respiratory and Critical Care Medicine
|October 31, 2006
PubMed
Summary

Lung transplant recipients face significant infection risks, even with modern treatments. Proactive prevention and tailored therapies are crucial for managing infections in these vulnerable patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Demographics and Geographic Accessibility of Invasive Fungal Infection Clinical Trial Sites.

JAMA network open·2026
Same author

Cytomegalovirus "Blips" and Rates of Progression to Clinically Significant CMV in Cardiothoracic Transplant Recipients.

Transplant infectious disease : an official journal of the Transplantation Society·2026
Same author

MMR and the EMR: Hunting for National-level Vaccine Data in Transplant Recipients.

Transplantation·2026
Same author

Burden of adverse transplant outcomes in kidney transplant recipients with COVID-19 and invasive fungal infections: a retrospective cohort study.

BMC infectious diseases·2026
Same author

Corticosteroid Therapy and Long-Term Outcomes of Post-Infectious Inflammatory Syndrome in Non-HIV Immunosuppressed Cryptococcal Meningitis: A Multicenter Case Series.

The Journal of infectious diseases·2026
Same author

Association Between Cytomegalovirus Viremia Clearance and Post-Solid Organ Transplant Mortality in Patients With Refractory Cytomegalovirus Infection: SOLSTICE Post Hoc Analysis.

Transplant international : official journal of the European Society for Organ Transplantation·2025

Area of Science:

  • Medicine
  • Immunology
  • Infectious Diseases

Background:

  • Infections are a leading cause of complications and death post-lung transplantation.
  • Lung transplant recipients are susceptible to a wide range of pathogens, both from the community and healthcare settings.
  • Increased immunosuppression intensity correlates with a higher risk of infection.

Purpose of the Study:

  • To review key pathogens affecting lung transplant recipients.
  • To discuss strategies for preventing and treating infections in this patient population.
  • To highlight the importance of recipient assessment for tailored prophylaxis.

Main Methods:

  • Literature review of infections in lung transplant recipients.
  • Analysis of prophylactic and therapeutic strategies for common and opportunistic pathogens.
  • Discussion of the impact of immunosuppression on infection risk.

Main Results:

  • Prophylaxis, such as for cytomegalovirus, has proven effective in reducing infection prevalence.
  • Treatment with isoniazid is recommended for tuberculin-positive individuals to prevent tuberculosis reactivation.
  • A variety of opportunistic pathogens can complicate transplantation due to immunosuppressive therapy.

Conclusions:

  • Effective infection management in lung transplant recipients requires careful assessment and targeted prophylaxis.
  • Strategies to prevent and treat specific pathogens are essential for improving outcomes.
  • Ongoing vigilance is necessary to combat the diverse infectious threats faced by these patients.

Related Experiment Videos